Approaches to Japanese Dose Evaluation in Global Drug Development: Factors That Generate Different Dosages Between Japan and the United States

[1]  M. Takeuchi,et al.  Differences Between Japan and the United States in Dosages of Drugs Recently Approved in Japan , 2011, Journal of clinical pharmacology.

[2]  Y. Uyama,et al.  PMDA's Challenge to Accelerate Clinical Development and Review of New Drugs in Japan , 2010, Clinical pharmacology and therapeutics.

[3]  Y. Uyama,et al.  Effective Global Drug Development Strategy for Obtaining Regulatory Approval in Japan in the Context of Ethnicity‐Related Drug Response Factors , 2010, Clinical pharmacology and therapeutics.

[4]  A. Kudrin.  Challenges in the Clinical Development Requirements for the Marketing Authorization of New Medicines in Southeast Asia , 2009, Journal of clinical pharmacology.

[5]  J. Sato,et al.  Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan , 2008, Journal of clinical pharmacology.

[6]  P. Honig.  Benefit and Risk Assessment in Drug Development and Utilization: A Role for Clinical Pharmacology , 2007, Clinical pharmacology and therapeutics.

[7]  C. Peck,et al.  “Getting the Dose Right”: Facts, a Blueprint, and Encouragements , 2007, Clinical pharmacology and therapeutics.

[8]  Yoshiaki Uyama,et al.  Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan , 2005, Clinical pharmacology and therapeutics.

[9]  Carl Peck,et al.  Postmarketing drug dosage changes of 499 FDA‐approved new molecular entities, 1980–1999 , 2002, Pharmacoepidemiology and drug safety.

[10]  John Urquhart,et al.  Changes in prescribed drug doses after market introduction , 2002, Pharmacoepidemiology and drug safety.

[11]  H. S. Struijker Boudier.  A drug is not a drug is not a drug: a commentary , 2002, Pharmacoepidemiology and drug safety.

[12]  Chikayuki Naito,et al.  Ethnic Factors in the Acceptability of Foreign Clinical Data , 1998 .

[13]  J. Shelley.  The Role of Clinical Pharmacology , 1988 .

[14]  R. F. Allen.  A Commentary , 1966 .